Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|August 7, 2014
[Hepatitis B infection in children]Vibeke Brix Christensen, Sannie Nordly, Mette Kjær, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 3, 2010
Quantitative MAIPA: Comparison of different MAIPA protocolsMette Kjær Killie, Wahida Salma, Eirin Bertelsen, et al.
Nutrients|August 14, 2025
The Role of Vitamin K Deficiency in Chronic Kidney Disease-A Scoping ReviewValdemar Tybjerg Wegge, Mette Kjær Torbensen, Allan Linneberg, et al.
Plos One|August 25, 2017
Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational studyMette Kjær, Heidi Tiller, Gøril Heide, et al.
Blood Advances|March 30, 2019
HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized womenJens Kjeldsen-Kragh, Thomas L Titze, Benedicte Alexandra Lie, et al.
Clinical & Developmental Immunology|November 24, 2011
The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypesMaria Therese Ahlen, Anne Husebekk, Mette Kjær Killie, et al.
European Journal of Gastroenterology & Hepatology|November 17, 2010
Lower liver stiffness in patients with sustained virological response 4 years after treatment for chronic hepatitis CEllen Sloth Andersen, Belinda Klemmensen Moessner, Peer Brehm Christensen, et al.
Expert Review of Hematology|November 19, 2010
Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and preventionBjørn Skogen, Mette Kjær Killie, Jens Kjeldsen-Kragh, et al.
Journal of Immunological Methods|April 10, 2016
Sensitive detection of platelet-specific antibodies with a modified MAIPA using biotinylated antibodies and streptavidin-coated beadsAnette Mörtberg, Stephan Meinke, Petra Berg, et al.
BMC Infectious Diseases|June 23, 2011
Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: a Danish nationwide cohort studyNanna Hansen, Niels Obel, Peer B Christensen, et al.
Pageof 2